	US 12,419,907 B2
	Photosynthetic cellular substances and methods of use thereof
Jose-Tomas Egana-Erazo, Santiago (CL)
Assigned to SYMBIOX, INC., San Diego, CA (US)
Filed by SYMBIOX, INC., San Diego, CA (US)
Filed on May 19, 2023, as Appl. No. 18/199,815.
Application 18/199,815 is a continuation of application No. 18/138,606, filed on Apr. 24, 2023.
Application 18/138,606 is a continuation of application No. 17/891,447, filed on Aug. 19, 2022.
Application 17/891,447 is a continuation of application No. 14/845,063, filed on Sep. 3, 2015, granted, now 11,452,740, issued on Sep. 27, 2022.
Claims priority of provisional application 62/092,229, filed on Dec. 15, 2014.
Claims priority of provisional application 62/045,523, filed on Sep. 3, 2014.
Claims priority of provisional application 62/045,527, filed on Sep. 3, 2014.
Claims priority of provisional application 62/045,524, filed on Sep. 3, 2014.
Claims priority of provisional application 62/045,530, filed on Sep. 3, 2014.
Claims priority of provisional application 62/045,525, filed on Sep. 3, 2014.
Claims priority of provisional application 62/045,528, filed on Sep. 3, 2014.
Prior Publication US 2023/0285449 A1, Sep. 14, 2023
Int. Cl. A61K 33/00 (2006.01); A61N 5/06 (2006.01)

CPC A61K 33/00 (2013.01) [A61N 5/0616 (2013.01); A61N 2005/0651 (2013.01)]

8 Claims

1. A method for improving a treatment or therapy of a human or animal body, comprising:

administering a composition to the human or animal body while the human or animal body is undergoing the treatment or therapy; and

wherein the composition comprises photosynthetic cellular structures and is formulated to generate and deliver oxygen to the human or animal body

wherein the treatment or therapy comprises a chemotherapy treatment, and wherein the composition is applied to cancerous cells;

wherein the treatment or therapy comprises a stem cell treatment or therapy, and wherein the composition comprises stem cells along with photosynthetic cellular structures;

wherein the composition comprises stem cells, and wherein the photosynthetic cellular structures provide a source of oxygen to the stem cells, and wherein the source of oxygen to the stem cells increases the effectiveness of the stem cell treatment or therapy;

wherein the treatment or therapy comprises a surgical procedure;

and wherein the photosynthetic cellular structures are injected into the blood to improve the ability of the blood to carry oxygen, wherein the photosynthetic cellular structures supplement or replace red blood cells and deliver oxygen.